Lyubica Dabich
- Pathology and Forensic Medicine top 5%
- Hematology top 5%
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Surgery
- Co-authors
- C. J. D. ZarafonetisS E RivkinSteve DahlbergDavid HeadEarl N. MetzWeick JkHerbert SloanMark B. Orringer
- Topics
- Systemic Sclerosis and Related Diseases (8 papers)Lymphoma Diagnosis and Treatment (6 papers)Acute Myeloid Leukemia Research (5 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Lyubica Dabich
27 papers receiving 700 citations
Peers
Comparison fields: 5 of 69
- Pathology and Forensic Medicine 284
- Hematology 278
- Public Health, Environmental and Occupational Health 216
- Oncology 183
- Surgery 137
Countries citing papers authored by Lyubica Dabich
This map shows the geographic impact of Lyubica Dabich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyubica Dabich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyubica Dabich more than expected).
Fields of papers citing papers by Lyubica Dabich
This network shows the impact of papers produced by Lyubica Dabich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyubica Dabich. The network helps show where Lyubica Dabich may publish in the future.
Co-authorship network of co-authors of Lyubica Dabich
This figure shows the co-authorship network connecting the top 25 collaborators of Lyubica Dabich. A scholar is included among the top collaborators of Lyubica Dabich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyubica Dabich. Lyubica Dabich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 14 | |
| 3 | Effect of cold stress on coronary sinus blood flow in patients with scleroderma. | 4 |
| 4 | Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance. | 22 |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 113 | |
| 8 | 4 | |
| 9 | 5 | |
| 10 | Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. | 9 |
| 11 | High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas. | 6 |
| 12 | 4 | |
| 13 | Combined Collis gastroplasty--fundoplication operations for scleroderma reflux esophagitis. | 51 |
| 14 | 19 | |
| 15 | 3 | |
| 16 | 20 | |
| 17 | 66 | |
| 18 | 21 | |
| 19 | 30 | |
| 20 | Late effects of thorotrast on the peripheral blood and bone marrow. | 0 |
About Lyubica Dabich
Lyubica Dabich is a scholar working on Pathology and Forensic Medicine, Hematology and Dermatology, having authored 29 papers that have together received 767 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (278 citations), Pathology and Forensic Medicine (284 citations) and Genetics (111 citations). Lyubica Dabich has collaborated with scholars based in United States and Canada. Frequent co-authors include C. J. D. Zarafonetis, S E Rivkin, Steve Dahlberg, David Head, Earl N. Metz, Weick Jk, Herbert Sloan, Mark B. Orringer, Jay S. Orringer and MB Orringer. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.